Total Positions
119
Quarter
2025 Q4
Top Holding
ABVX (9.1%)
Top 10 Concentration
45.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 119
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABVX
ABIVAX SA
|
Healthcare | 9.06% | 2.83% |
#1
10
Prev: #11
|
5.9 | 225,510 | 135.6% |
P
S
|
391,783 | $52,833,896 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 6.70% | 5.42% |
#2
1
Prev: #3
|
4.7 | 160,689 | 22.1% |
P
S
|
886,893 | $39,067,637 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 4.95% | 3.18% |
#3
4
Prev: #7
|
4.2 | 498,729 | 76.1% |
P
S
|
1,154,114 | $28,864,391 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 4.83% | 4.21% |
#4
2
Prev: #6
|
1.9 | -26,826 | -2.0% |
P
S
|
1,339,379 | $28,140,353 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 4.19% | 0.73% |
#5
31
Prev: #36
|
4.0 | 221,738 | 171.4% |
P
S
|
351,073 | $24,417,127 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACLX
ARCELLX INC
|
Healthcare | 3.72% | 0.19% |
#6
56
Prev: #62
|
3.8 | 321,484 | 2826.0% |
P
S
|
332,860 | $21,702,472 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 3.60% | 12.72% |
#7
6
Prev: #1
|
1.7 | -3,230,489 | -77.0% |
P
S
|
966,698 | $20,977,347 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 2.97% | 0.13% |
#8
65
Prev: #73
|
3.5 | 339,581 | 378.9% |
P
S
|
429,198 | $17,339,599 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TWST
TWIST BIOSCIENC...
|
Healthcare | 2.82% | — |
#9
Prev: #—
|
3.1 | 518,355 | no change |
NEW
|
518,355 | $16,442,221 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 2.81% | 5.13% |
#10
6
Prev: #4
|
1.3 | -944,621 | -59.4% |
P
S
|
644,959 | $16,394,858 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 2.80% | 1.20% |
#11
15
Prev: #26
|
3.3 | 360,588 | 76.0% |
P
S
|
835,200 | $16,336,512 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 2.68% | 1.55% |
#12
9
Prev: #21
|
3.3 | 156,310 | 81.3% |
P
S
|
348,605 | $15,624,476 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRZN
SURROZEN INC
|
Healthcare | 2.17% | 1.84% |
#13
2
Prev: #15
|
0.9 | -93,697 | -13.1% |
P
S
|
619,766 | $12,672,108 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CELC
CELCUITY INC
|
Healthcare | 2.02% | 1.35% |
#14
9
Prev: #23
|
0.8 | -18,377 | -13.4% |
P
S
|
118,333 | $11,802,533 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 1.80% | 1.20% |
#15
12
Prev: #27
|
3.0 | 131,937 | 83.4% |
P
S
|
290,049 | $10,525,878 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 1.77% | 0.75% |
#16
17
Prev: #33
|
3.0 | 9,529 | 116.1% |
P
S
|
17,736 | $10,328,382 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADPT
ADAPTIVE BIOTEC...
|
Healthcare | 1.69% | — |
#17
Prev: #—
|
2.7 | 606,825 | no change |
NEW
|
606,825 | $9,854,838 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 1.69% | — |
#18
Prev: #—
|
2.7 | 4,192,375 | no change |
NEW
|
4,192,375 | $9,852,081 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 1.60% | — |
#19
Prev: #—
|
2.6 | 146,978 | no change |
NEW
|
146,978 | $9,338,982 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.54% | — |
#20
Prev: #—
|
2.6 | 360,876 | no change |
NEW
|
360,876 | $8,955,138 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 1.30% | — |
#21
Prev: #—
|
2.5 | 97,340 | no change |
NEW
|
97,340 | $7,596,414 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 1.29% | 0.61% |
#22
17
Prev: #39
|
2.8 | 125,073 | 235.1% |
P
S
|
178,274 | $7,537,425 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 1.24% | — |
#23
Prev: #—
|
2.5 | 35,000 | no change |
NEW
|
35,000 | $7,243,250 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 1.19% | 5.05% |
#24
19
Prev: #5
|
0.7 | -1,315,601 | -75.8% |
P
S
|
419,058 | $6,918,648 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 1.17% | 0.75% |
#25
9
Prev: #34
|
2.8 | 288,256 | 104.1% |
P
S
|
565,140 | $6,826,891 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 0.00% | 3.09% |
Sold All 😨
(Was: #8) |
0.3 | -2,110,152 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 0.00% | 3.06% |
Sold All 😨
(Was: #9) |
0.3 | -1,017,311 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 0.00% | 2.92% |
Sold All 😨
(Was: #10) |
0.3 | -152,325 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGENX SE
|
Healthcare | 0.00% | 1.84% |
Sold All 😨
(Was: #14) |
0.3 | -12,465 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RZLT
REZOLUTE INC
|
Healthcare | 0.00% | 1.73% |
Sold All 😨
(Was: #17) |
0.3 | -917,630 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GHRS
GH RESEARCH PLC
|
Healthcare | 0.00% | 1.56% |
Sold All 😨
(Was: #18) |
0.3 | -545,275 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.00% | 1.45% |
Sold All 😨
(Was: #22) |
0.3 | -241,637 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.00% | 1.33% |
Sold All 😨
(Was: #24) |
0.3 | -127,435 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 0.00% | 1.25% |
Sold All 😨
(Was: #25) |
0.3 | -43,419 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 1.16% |
Sold All 😨
(Was: #28) |
0.3 | -121,410 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 0.00% | 1.03% |
Sold All 😨
(Was: #29) |
0.3 | -39,072 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
AVIDITY BIOSCIE...
|
Healthcare | 0.00% | 1.00% |
Sold All 😨
(Was: #30) |
0.3 | -114,053 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.00% | 0.59% |
Sold All 😨
(Was: #41) |
0.3 | -188,999 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HROW
HARROW INC
|
Healthcare | 0.00% | 0.56% |
Sold All 😨
(Was: #42) |
0.3 | -57,619 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EQ
EQUILLIUM INC
|
Healthcare | 0.00% | 0.55% |
Sold All 😨
(Was: #44) |
0.3 | -1,908,935 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 0.00% | 0.53% |
Sold All 😨
(Was: #45) |
0.3 | -6,264 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 0.00% | 0.51% |
Sold All 😨
(Was: #46) |
0.3 | -63,019 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QQQ
INVESCO QQQ TR
|
ETF | 0.00% | 0.46% |
Sold All 😨
(Was: #47) |
0.3 | -3,797 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 0.00% | 0.41% |
Sold All 😨
(Was: #49) |
0.3 | -245,378 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.00% | 0.40% |
Sold All 😨
(Was: #50) |
0.3 | -166,461 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PEPG
PEPGEN INC
|
Healthcare | 0.00% | 0.36% |
Sold All 😨
(Was: #52) |
0.3 | -389,189 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PCSC
PERCEPTIVE CAP ...
|
Financial Services | 0.00% | 0.32% |
Sold All 😨
(Was: #55) |
0.3 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 0.00% | 0.32% |
Sold All 😨
(Was: #56) |
0.3 | -363,666 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 0.00% | 0.32% |
Sold All 😨
(Was: #57) |
0.3 | -275,620 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PYXS
PYXIS ONCOLOGY ...
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #58) |
0.3 | -689,538 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
CALL
BIOHAVEN LTD
|
CALL Option | 0.00% | 0.24% |
Sold All 😨
(Was: #60) |
0.3 | -480,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MNMD
MIND MEDICINE M...
|
Healthcare | 0.00% | 0.18% |
Sold All 😨
(Was: #64) |
0.3 | -76,875 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ENTA
ENANTA PHARMACE...
|
Healthcare | 0.00% | 0.18% |
Sold All 😨
(Was: #66) |
0.3 | -75,194 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #67) |
0.3 | -38,742 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 0.00% | 0.15% |
Sold All 😨
(Was: #69) |
0.3 | -1,490,100 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.00% | 0.14% |
Sold All 😨
(Was: #70) |
0.3 | -96,439 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 0.00% | 0.14% |
Sold All 😨
(Was: #71) |
0.3 | -56,770 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARCT
ARCTURUS THERAP...
|
Healthcare | 0.00% | 0.13% |
Sold All 😨
(Was: #74) |
0.3 | -35,606 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VTYX
VENTYX BIOSCIEN...
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #75) |
0.3 | -167,470 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATAI
ATAI LIFE SCIEN...
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #76) |
0.3 | -76,032 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
CALL
IONIS PHARMACEU...
|
CALL Option | 0.00% | 0.03% |
Sold All 😨
(Was: #80) |
0.3 | -50,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRSP
CALL
CRISPR THERAPEU...
|
CALL Option | 0.00% | 0.01% |
Sold All 😨
(Was: #81) |
0.3 | -40,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
CALL
SYNDAX PHARMACE...
|
CALL Option | 0.00% | 0.01% |
Sold All 😨
(Was: #82) |
0.3 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
CALL
IMMUNOVANT INC
|
CALL Option | 0.00% | 0.01% |
Sold All 😨
(Was: #83) |
0.3 | -250,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARKG
CALL
ARK ETF TR
|
CALL Option | 0.00% | 0.01% |
Sold All 😨
(Was: #84) |
0.3 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
PUT
AKERO THERAPEUT...
|
PUT Option | 0.00% | 0.00% |
Sold All 😨
(Was: #86) |
0.3 | -15,500 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABUS
CALL
ARBUTUS BIOPHAR...
|
CALL Option | 0.00% | 0.00% |
Sold All 😨
(Was: #87) |
0.3 | -95,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 119 holdings